tiprankstipranks
Trending News
More News >
Cormedix (CRMD)
NASDAQ:CRMD
US Market
Advertisement

Cormedix (CRMD) Technical Analysis

Compare
1,476 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Cormedix’s (CRMD) Moving Averages Convergence Divergence (MACD) indicator is -0.37, suggesting Cormedix is a Buy.
Cormedix’s (CRMD) 20-Day exponential moving average is 11.67, while Cormedix’s (CRMD) share price is $11.27, making it a Sell.
Cormedix’s (CRMD) 50-Day exponential moving average is 12.04, while Cormedix’s (CRMD) share price is $11.27, making it a Sell.

Cormedix (CRMD) Pivot Points

Oct 09, 2025, 05:15 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.84
11.05
11.30
11.51
11.76
11.97
12.22
Fibonacci
11.05
11.22
11.33
11.51
11.68
11.79
11.97
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cormedix (CRMD) Moving Averages

Oct 09, 2025, 05:15 PM
Period
Simple
Exponential
MA5
11.22Sell
11.28Sell
MA10
11.32Sell
11.38Sell
MA20
11.65Sell
11.67Sell
MA50
12.27Sell
12.04Sell
MA100
12.46Sell
11.90Sell
MA200
11.05Buy
11.24Sell
Cormedix’s (CRMD) 10-Day exponential moving average is 11.38, while Cormedix’s (CRMD) share price is $11.27, making it a Sell.
Cormedix’s (CRMD) 100-Day exponential moving average is 11.90, while Cormedix’s (CRMD) share price is $11.27, making it a Sell.
Cormedix’s (CRMD) stock price is $11.27 and Cormedix’s (CRMD) 50-day simple moving average is 12.27, creating a Sell signal.
Cormedix’s (CRMD) stock price is $11.27 and Cormedix’s (CRMD) 100-day simple moving average is 12.46, creating a Sell signal.
Cormedix’s (CRMD) stock price is $11.27 and Cormedix’s (CRMD) 200-day simple moving average is 11.05, creating a Buy signal.

Cormedix (CRMD) Technical Indicators

Oct 09, 2025, 05:15 PM
Name
Value
Implied Action
RSI (14)
41.49
Neutral
STOCH (9,6)
28.36
Neutral
STOCHRSI (14)
26.30
Neutral
MACD (12,26)
-0.37
Buy
ADX (14)
13.76
Buy
Williams %R
-89.55
Buy
CCI (14)
-56.35
Neutral
ATR (14)
0.62
-
Ultimate Oscillator
37.88
Neutral
ROC
-0.27
Sell
Cormedix’s (CRMD) Relative Strength Index (RSI) is 41.49, creating a Neutral signal.
Cormedix’s (CRMD) Trend Strength Indicator (ADX) is 13.76, creating a Buy signal.
Cormedix’s (CRMD) Commodity Channel Index (CCI) is -56.35, creating a Neutral signal.
Cormedix’s (CRMD) Price Rate of Change (ROC) is -0.27, creating a Sell signal.

FAQ

Is CRMD a Buy, Hold, or Sell?
Based on CRMD’s technical indicators, CRMD is a Sell.
    What is CRMD’s RSI (14)?
    CRMD’s RSI (14) is 41.49, which suggests CRMD is a Neutral.
      What is CRMD’s MACD?
      CRMD’s MACD is -0.37, which suggests CRMD is a Buy.
        What is CRMD’s 5-day moving average?
        CRMD’s 5-day moving average is 11.22, which suggests CRMD is a Sell.
          What is CRMD’s 20-day moving average?
          CRMD 20-day moving average is 11.65, which suggests CRMD is a Sell.
            What is CRMD’s 50-day moving average?
            CRMD’s 50-day moving average is 12.27, which suggests CRMD is a Sell.
              What is CRMD’s 200-day moving average?
              CRMD’s 200-day moving average is 11.05, which suggests CRMD is a Buy.
                What is CRMD’s Williams % R (14)?
                CRMD’s Williams % R (14) is -89.55, which suggests CRMD is a Buy.
                  What is CRMD’s CCI (14)?
                  CRMD’s CCI (14) is -56.35, which suggests CRMD is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis